New approach towards cytotoxic furyl macrolactones by ring closing metathesis. 2006

J Krauss, and F Bracher, and D Unterreitmeier
Department of Pharmacy, Zentrum für Pharmaforschung, Munich, Germany. hjkra@cup.uni-muenchen.de

Furan-2-ylalkenols 2a-d were esterified with undec-10-enoyl chloride and the resulting esters were cyclized to unsaturated 2- and 3-furyl macrolactones by ring closing metathesis using Grubbs catalyst I. Hydrolysis of the macrolactone 4b with NaOH led to the furylalkenoic acid and reaction of 4c with tert-butyllithium gave a tert-butyl ketone. Some of the resulting compounds were tested in the MTT assay for their cytotoxic activities against HL 60 cells and at the National Cancer Institute (NCI) against 60 cancer cell lines. The compounds only showed cytotoxic activities in the muM range.

UI MeSH Term Description Entries
D007783 Lactones Cyclic esters of hydroxy carboxylic acids, containing a 1-oxacycloalkan-2-one structure. Large cyclic lactones of over a dozen atoms are MACROLIDES. Lactone
D005663 Furans Compounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran. Tetrahydrofurans
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D018922 HL-60 Cells A promyelocytic cell line derived from a patient with ACUTE PROMYELOCYTIC LEUKEMIA. HL-60 cells lack specific markers for LYMPHOID CELLS but express surface receptors for FC FRAGMENTS and COMPLEMENT SYSTEM PROTEINS. They also exhibit phagocytic activity and responsiveness to chemotactic stimuli. (From Hay et al., American Type Culture Collection, 7th ed, pp127-8) HL60 Cells,Cell, HL60,Cells, HL60,HL 60 Cells,HL-60 Cell,HL60 Cell

Related Publications

J Krauss, and F Bracher, and D Unterreitmeier
November 2007, The Journal of organic chemistry,
J Krauss, and F Bracher, and D Unterreitmeier
August 2007, Organic letters,
J Krauss, and F Bracher, and D Unterreitmeier
February 2005, Organic letters,
J Krauss, and F Bracher, and D Unterreitmeier
January 2005, Organic & biomolecular chemistry,
J Krauss, and F Bracher, and D Unterreitmeier
September 2002, Chemical communications (Cambridge, England),
J Krauss, and F Bracher, and D Unterreitmeier
August 2009, Chemical reviews,
J Krauss, and F Bracher, and D Unterreitmeier
October 2020, Molecules (Basel, Switzerland),
J Krauss, and F Bracher, and D Unterreitmeier
February 2007, Organic letters,
J Krauss, and F Bracher, and D Unterreitmeier
October 2005, The Journal of organic chemistry,
J Krauss, and F Bracher, and D Unterreitmeier
August 2005, Journal of the American Chemical Society,
Copied contents to your clipboard!